Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Eyes and Eyes With Ocular Pathologies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07355491
What this trial is testing

Performance Evaluation of Dream OCT: AP Study

Who this might be right for
Glaucoma PatientsRetina PatientsEyes With Corneal Abnormality+1 more
Intalight, Inc 120
Not applicableStudy completedNCT02370225
What this trial is testing

Aerobic Exercise in Primary Sjögren's Syndrome

Who this might be right for
Sjogren's Syndrome
Samira Tatiyama Miyamoto, PhD 45
Early research (Phase 1)Study completedNCT01273090
What this trial is testing

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more
Children's Oncology Group 34
Not applicableStudy completedNCT05945784
What this trial is testing

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Who this might be right for
Stroke, IschemicStroke HemorrhagicStroke (CVA) or TIA+11 more
Casa Colina Hospital and Centers for Healthcare 57
Testing effectiveness (Phase 2)Study completedNCT01273766
What this trial is testing

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more
Wake Forest University Health Sciences 16
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Early research (Phase 1)UnknownNCT00023816
What this trial is testing

Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00025415
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60
Not applicableWithdrawnNCT00406120
What this trial is testing

Validation of a Molecular Prognostic Test for Eye Melanoma

Who this might be right for
Uveal NeoplasmsChoroid NeoplasmsIris Neoplasms
Washington University School of Medicine
Not applicableUnknownNCT04281732
What this trial is testing

Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision

Who this might be right for
Low VisionRetinitis PigmentosaStargardt Disease 1+3 more
Queen's University, Belfast 20
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Early research (Phase 1)Study completedNCT00030108
What this trial is testing

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT02648581
What this trial is testing

Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease

Who this might be right for
Behçet Disease
Assistance Publique - Hôpitaux de Paris 16
Not applicableLooking for participantsNCT07364474
What this trial is testing

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Who this might be right for
Uveal Melanoma
Massachusetts General Hospital 10
Not applicableStudy completedNCT03410290
What this trial is testing

Journey of Patients With Vasculitis From First Symptom to Diagnosis

Who this might be right for
VasculitisSystemic VasculitisBehcet's Disease+13 more
University of Pennsylvania 456
Not applicableStudy completedNCT03284268
What this trial is testing

Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma

Who this might be right for
Retinoblastoma, Recurrent
Fundació Sant Joan de Déu 13
Testing effectiveness (Phase 2)Study completedNCT05443685
What this trial is testing

ADX-629 Therapy for Sjogren-Larsson Syndrome

Who this might be right for
Sjogren-Larsson Syndrome
University of Nebraska 8
Very early researchEnded earlyNCT04839315
What this trial is testing

COVID-19 Vaccination in Rheumatic Disease Patients

Who this might be right for
Systemic Lupus ErythematosusSjogren's SyndromeInflammatory Myositis+5 more
Mayo Clinic 58
Testing effectiveness (Phase 2)Study completedNCT00002502
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00003395
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Next Page